IP Library Granted Patent US 9,982,268
Granted Patent B2
US 9,982,268 · App. 12/167,527 · Granted May 29, 2018

Vectors for cloning

Inventor: Arvydas Lubys (Vilnius, LT)
Assignee: Thermo Fisher Scientific Baltics UAB
C12N15/64C12N15/65
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,982,268
App. No.
12/167,527
Granted
May 29, 2018
Kind
B2
Abstract

A vector for transformation into a host cell is described comprising a toxic gene encoding a product that is lethal to the host cell, wherein the toxic gene comprises: an essential sequence region whose integrity is necessary in order for the encoded toxic gene product to be lethal to the host cell; an inessential sequence region whose integrity is not essential in order for the encoded toxic gene product to be lethal to the host cell; a regulatory sequence inserted in-frame into the inessential sequence region; and a cloning site within the essential sequence region for insertion of a nucleic acid sequence, wherein the regulatory sequence and the cloning site are positioned so as to allow the regulatory sequence to be operably linked to a nucleic acid sequence when the nucleic acid sequence is inserted into the cloning site.

Claims (29)

1. A positive selection vector for transformation into a host cell comprising a toxic gene encoding a product that is lethal to the host cell, wherein the toxic gene comprises:

an essential sequence region whose integrity is necessary in order for the encoded toxic gene product to be lethal to the host cell;

an inessential sequence region which encodes a section of the toxic product and whose integrity is not essential in order for the encoded toxic gene product to be lethal to the host cell;

a regulatory sequence inserted in-frame into the inessential sequence region and encoding amino acids additional to the encoded toxic gene product; and

a cloning site within the essential sequence region for insertion of a nucleic acid sequence,

wherein the regulatory sequence and the cloning site are positioned so as to allow the regulatory sequence to be operably linked to a nucleic acid sequence when the nucleic acid sequence is inserted into the cloning site and wherein the toxic gene encodes a nuclease.

2. A vector according to claim 1 wherein the toxic gene is eco47IR.

3. A vector according to claim 1 wherein the regulatory sequence is a T7 promoter sequence.

4. A vector according to claim 1 wherein the toxic gene is eco47IR, the regulatory sequence is a T7 promoter sequence, the cloning site is an Eco32I site and the vector further comprises a replication region and an ampicillin resistance gene.

5. A vector according to claim 1 further comprising a nucleic acid molecule inserted into the toxic gene at the cloning site.

6. A recombinant host cell comprising the vector of claim 1 .

7. A kit for cloning of a nucleic acid molecule, comprising the vector of claim 1 .

8. A method for producing a positive selection vector of claim 1 comprising the steps of:

a) selecting a vector comprising a toxic gene encoding a product that is lethal to the host cell; and

b) inserting a regulatory sequence into the sequence of the toxic gene at an inessential region of the toxic gene which encodes a section of the toxic product and whose integrity is not essential in order for the encoded toxic gene product to be lethal to the host cell;

wherein the sequence of the toxic gene further comprises a cloning site at a region within the sequence of the toxic gene whose integrity is essential in order for the product encoded by the toxic gene to be lethal to the host cell and wherein the toxic gene encodes a nuclease.

9. A method according to claim 8 , further comprising the step of introducing the cloning site into the toxic gene sequence by site-specific mutagenesis.

10. A method of cloning a nucleic acid molecule comprising the steps of:

a) cutting a positive selection vector according to claim 1 at the cloning site to create a linearized vector; and

b) ligating the nucleic acid molecule into the linearized vector to form a circularised vector product.

11. A method of expressing a nucleic acid molecule comprising transforming the vector of claim 5 into a host cell, and culturing the cell under conditions suitable for expression of the nucleic acid molecule.

12. A positive selection vector for transformation into a host cell comprising a toxic gene encoding a product that is lethal to the host cell, wherein the toxic gene comprises:

an essential sequence region whose integrity is necessary in order for the encoded toxic gene product to be lethal to the host cell;

an inessential sequence region which encodes a section of the toxic product and whose integrity is not essential in order for the encoded toxic gene product to be lethal to the host cell;

a promoter sequence inserted in-frame into the inessential sequence region; and

a cloning site within the essential sequence region for insertion of a nucleic acid sequence,

wherein the promoter sequence and the cloning site are positioned so as to allow the promoter sequence to be operably linked to a nucleic acid sequence when the nucleic acid sequence is inserted into the cloning site,

wherein the toxic gene is eco47IR,

and wherein the promoter sequence comprises a T7, SP6, T3, phage lambda PL, phage lambda PR, Plac type, or a ParaBAD promoter.

Assignments (2)
CHANGE OF NAME Recorded Jul 31, 2014
From: FERMENTAS UAB
To: THERMO FISHER SCIENTIFIC BALTICS UAB
Reel/Frame 033452/0092 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2008
From: LUBYS, ARVYDAS
To: FERMENTAS UAB
Reel/Frame 021586/0445 →
Priority Claims (1)
GB 0713179.0 · Jul 6, 2007 · national
Continuity (1)
Related Publication 20090042249A1 · Feb 12, 2009